Martingale Asset Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.91M Sell
154,232
-5,348
-3% -$122K 0.09% 232
2026
Q1
$3.41M Sell
159,580
-10,018
-6% -$209K 0.09% 228
2025
Q4
$3.63M Sell
169,598
-8,567
-5% -$176K 0.09% 199
2025
Q3
$2.98M Buy
178,165
+605
+0.3% +$9.07K 0.08% 228
2025
Q2
$2.55M Buy
177,560
+109,000
+159% +$1.49M 0.06% 258
2025
Q1
$993K Sell
68,560
-12,408
-15% -$176K 0.03% 460
2024
Q4
$1.06M Sell
80,968
-6,098
-7% -$84.2K 0.03% 464
2024
Q3
$1.01M Buy
87,066
+55,966
+180% +$528K 0.02% 454
2024
Q2
$235K Sell
31,100
-31,401
-50% -$260K 0.01% 732
2024
Q1
$627K Hold
62,501
0.01% 571
2023
Q4
$581K Buy
62,501
+1,500
+2% +$15.5K 0.01% 576
2023
Q3
$775K Buy
61,001
+48,700
+396% +$668K 0.02% 514
2023
Q2
$175K Sell
12,301
-6,500
-35% -$91.3K ﹤0.01% 775
2023
Q1
$280K Buy
+18,801
New +$285K 0.01% 720
2020
Q4
Sell
-20,432
Closed -$333K 985
2020
Q3
$333K Buy
+20,432
New +$380K ﹤0.01% 892

Other funds holding MD

Martingale Asset Management's MD Position: Q2 2026 in Review

Martingale Asset Management reduced its Pediatrix Medical (MD) stake by 3.4% in Q2 2026, selling an estimated $122K and leaving 154,232 shares worth $3.91M. The position accounts for 0.09% of the portfolio, ranked #232.

Martingale Asset Management first reported a position in MD in Q3 2020 and has held it in 15 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Martingale Asset Management held 154,232 shares of Pediatrix Medical worth $3.91M as of Q2 2026.
  • Martingale Asset Management sold 5,348 Pediatrix Medical shares in Q2 2026, an estimated $122K.
  • Pediatrix Medical made up 0.09% of Martingale Asset Management's portfolio in Q2 2026, its #232 holding.
  • Martingale Asset Management first reported a position in Pediatrix Medical in Q3 2020 and has held it in 15 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.